Vosselaar, Belgium

Philip Erna H Heyns

This inventor holds 2 USPTO granted patents and 9 published patent applications and 2 EPO patents. Top assignees: Janssen Pharmaceutica Nv, Janssen Sciences Ireland Uc. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip Erna H Heyns. Retrieved from https://idiyas.com/inventor/philip-erna-h-heyns-fmfejtk7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.4

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Philip Erna H Heyns

Introduction

Philip Erna H Heyns is a notable inventor based in Vosselaar, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of HIV treatments. His work has led to advancements that benefit patients worldwide.

Latest Patents

One of his key inventions is related to Darunavir combination formulations. This patent focuses on solid oral dosage forms of the HIV inhibitor Darunavir and/or a pharmaceutically acceptable salt or solvate thereof, along with combination formulations. This innovation is crucial in enhancing the effectiveness of HIV treatment options.

Career Highlights

Philip is currently associated with Janssen Sciences Ireland UC, where he continues to work on groundbreaking pharmaceutical developments. His expertise in the field has positioned him as a valuable asset in the fight against HIV.

Collaborations

Throughout his career, Philip has collaborated with esteemed colleagues such as Urbain Alfons C Delaet and Eugeen Maria Jozef Jans. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Philip Erna H Heyns exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the development of Darunavir formulations, highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…